epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

melatonin

common name

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • acute kidney injury [Insufficient Evidence]
  • ADHD [Insufficient Evidence]
  • age-related macular degeneration [Insufficient Evidence]
  • athletic performance [Possibly Ineffective]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • autism spectrum disorder [Insufficient Evidence]
  • benzodiazepine withdrawal [Likely Ineffective]
  • bipolar disorder [Insufficient Evidence]
  • BPH [Insufficient Evidence]
  • bronchopulmonary dysplasia [Insufficient Evidence]
  • CABG [Insufficient Evidence]
  • cachexia [Possibly Ineffective]
  • cancer, adjunct tx [Possibly Effective]
  • cancer-related fatigue [Possibly Ineffective]
  • cancer-related pain [Possibly Ineffective]
  • chronic fatigue syndrome [Insufficient Evidence]
  • cluster headache [Insufficient Evidence]
  • cognitive impairment [Insufficient Evidence]
  • colorectal CA [Insufficient Evidence]
  • contraception [Insufficient Evidence]
  • COPD [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • critical illness (trauma) [Possibly Ineffective]
  • delayed sleep phase syndrome [Likely Effective]
  • delirium [Insufficient Evidence]
  • dementia [Possibly Ineffective]
  • depression [Likely Ineffective]
  • diabetes mellitus [Insufficient Evidence]
  • diabetic neuropathy [Insufficient Evidence]
  • dysmenorrhea [Insufficient Evidence]
  • dyspepsia [Insufficient Evidence]
  • emergence delirium [Possibly Effective]
  • endometriosis [Insufficient Evidence]
  • endotracheal intubation-related hemodynamic effects [Insufficient Evidence]
  • epilepsy [Insufficient Evidence]
  • fibromyalgia [Insufficient Evidence]
  • GERD [Insufficient Evidence]
  • H. pylori infection [Insufficient Evidence]
  • heart failure [Insufficient Evidence]
  • HTN [Possibly Effective]
  • IBS [Insufficient Evidence]
  • infertility in patients of childbearing potential [Possibly Ineffective]
  • insomnia [Possibly Effective]
  • ischemic reperfusion injury [Insufficient Evidence]
  • jet lag [Possibly Effective]
  • lung CA [Insufficient Evidence]
  • melasma [Insufficient Evidence]
  • menopausal symptoms [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
  • metabolic syndrome [Insufficient Evidence]
  • MI [Insufficient Evidence]
  • migraine prophylaxis [Possibly Effective]
  • multiple sclerosis [Insufficient Evidence]
  • neonatal encephalopathy [Insufficient Evidence]
  • nocturnal enuresis [Insufficient Evidence]
  • non-24h sleep-wake disorder, blind patients [Likely Effective]
  • obesity [Insufficient Evidence]
  • oral mucositis, chemo-or XRT-related [Insufficient Evidence]
  • osteopenia [Insufficient Evidence]
  • osteoporosis [Insufficient Evidence]
  • pain, acute [Insufficient Evidence]
  • pain, chronic [Insufficient Evidence]
  • periodontitis [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • postop nausea/vomiting [Insufficient Evidence]
  • postop pain [Insufficient Evidence]
  • postop recovery [Insufficient Evidence]
  • postop sleep disturbance [Insufficient Evidence]
  • postural tachycardia syndrome [Insufficient Evidence]
  • pre-eclampsia [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • preop anxiety [Possibly Effective]
  • preop sedation [Possibly Effective]
  • prostate CA [Insufficient Evidence]
  • pruritus [Insufficient Evidence]
  • psoriasis [Insufficient Evidence]
  • radiation dermatitis [Insufficient Evidence]
  • REM sleep behavior disorder [Insufficient Evidence]
  • renal failure [Insufficient Evidence]
  • renal transplant [Insufficient Evidence]
  • restless legs syndrome [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • sarcoidosis [Insufficient Evidence]
  • schizophrenia [Insufficient Evidence]
  • seasonal affective disorder [Insufficient Evidence]
  • sepsis [Insufficient Evidence]
  • shift-work disorder [Possibly Ineffective]
  • smoking cessation [Insufficient Evidence]
  • stabbing headache [Insufficient Evidence]
  • stress [Insufficient Evidence]
  • sunburn [Possibly Effective]
  • tardive dyskinesia [Insufficient Evidence]
  • temporomandibular disorder [Possibly Effective]
  • tension-type headache [Insufficient Evidence]
  • thrombocytopenia, chemo-related [Possibly Effective]
  • tinnitus [Insufficient Evidence]
  • traumatic brain injury [Insufficient Evidence]
  • ulcerative colitis [Insufficient Evidence]
  • xerostomia [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information